Neurostimulation Devices Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2018-2024. Increasing prevalence of diseases that are treated with neurostimulation therapy is the major growth factor of the global neurostimulation devices market.
Scope of Global Neurostimulation Devices Market Reports –
Neurostimulation devices are implantable, programmable medical devices that deliver electrical stimulation to specific part of the patient’s brain, spinal cord or peripheral nervous system to help treat various conditions, including chronic pain, movement disorders, epilepsy and Parkinson’s disease. Neuromodulation is an intracranial, electrical neuromodulation therapy that has FDA approval for the treatment for most of the neurological diseases such as bladder control, headache, tremors, chronic pain, stroke, minimally conscious state, and spinal cord injury, which are most commonly found in the elderly population. The proven efficacy and improving acceptance of this technology are expected to lead to the surge in the market demand during the forecast period.
Get Sample Copy of This Premium Report @ https://brandessenceresearch.biz/Request/Sample?ResearchPostId=5077&RequestType=Sample
Global neurostimulation devices market report is segmented on the basis of type, application, end users and by regional & country level. Based on type global neurostimulation devices market is classified as implantable and external. Based upon application, global neurostimulation devices market is classified as dystonia, epilepsy, Parkinson’s disease, depression, gastroparesis, pain management, tremors, urinary and fecal incontinence. Based upon end users, global neurostimulation devices market is classified into hospitals/clinics, cognitive care centers, research institutes, others
The regions covered in this neurostimulation devices market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of neurostimulation devices is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.
Key Players for Global Neurostimulation Devices Market Reports-
Global Neurostimulation Devices market report covers prominent players like Autonomic Technologies, Boston Scientific, ElectroCore, ImThera Medical, Inspire Medical Systems, LivaNova (Cyberonics), Medtronic, NeuroMetrix, NeuroPace, Neuros Medical, and others.
Medtronic Announces FDA Approval and U.S. Launch of Next Generation Spinal Cord Stimulator for Chronic Pain Management
News: – September 18, 2017, Medtronic plc announced FDA approval and U.S. launch of the Intellis (TM) platform for the management of certain types of chronic intractable pain. The Intellis platform was designed to overcome limitations with current spinal cord stimulation (SCS) systems, such as battery performance, and can power the Evolve SM workflow, which standardizes guidance and balances high-dose (HD) and low-dose (LD) therapy settings. The Intellis platform can record and track patient activity 24/7 and is managed on the Samsung Galaxy Tab S2 tablet interface, enabling physicians to address the subjective and personal nature of chronic pain by monitoring progress and making modifications to better suit their patients’ therapy needs.
Request for Methodology @ https://brandessenceresearch.biz/Request/Sample?ResearchPostId=5077&RequestType=Methodology
Global Neurostimulation Devices Market Dynamics –
Increasing incidence of neurological disorders and lifestyle–related disorders, rising external funding for R&D, and demand for minimally invasive surgeries are some factors driving the market growth. According to the American Academy of Neurology, stroke is ranked as the third leading cause of death in U.S., with Alzheimer’s being ranked as the sixth leading cause of death. Figures from the same source specify that Parkinson’s affects nearly 1 million Americans annually with at least a minimum of 60,000 new cases that are reported annually. However, the lack of well-trained professionals and non-measurable outcomes are affecting the growth of the neurostimulation devices market. Moreover, the need to provide safe and improved care to patients suffering from neurological disorders and government support in emerging countries are expected to generate new market opportunities over the forecast period.
Global Neurostimulation Devices Market Regional Analysis –
North America dominates the neurostimulation devices market due to high prevalence of chronic diseases and the growing geriatric population. For instance, according to the Centers for Disease Control and Prevention (CDC), in 2015 approximately 23.1 million people in the U.S. had diabetes. In addition according to National Institutes of Health, in the U.S. approximately one million people have Parkinson’s disease. As per the Alzheimer’s Association in 2017, 5.5 million Americans had Alzheimer and about 5.3 million of this patient population’s age was 65 years or more. In addition, Alzheimer’s Association estimated approximately 14 million people are expected to suffer from Alzheimer in 2050.
Asia-Pacific is observed to witness the fastest growing region in this market. Increasing occurrence of diabetes, growing geriatric population and rising adoption of neurostimulation devices are some factors which makes positive impact on the neurostimulation device market growth in the region.
Key Benefits for Global Neurostimulation Devices Market Reports –
- Global Neurostimulation Devices Market report covers in depth historical and forecast analysis.
- Global Neurostimulation Devices Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
- Global Neurostimulation Devices Market report helps to identify opportunities in market place.
- Global Neurostimulation Devices Market report covers extensive analysis of emerging trends and competitive landscape.
Get Full information of This Report @ https://brandessenceresearch.biz/Lifesciences-and-Healthcare/Global-Neurostimulation-Devices-Market/Summary
Global Neurostimulation Devices Market Segmentation –
Global Neurostimulation Devices Market: by Type analysis
- Implantable
- External
Global Neurostimulation Devices Market: by Application analysis
- Dystonia
- Epilepsy
- Parkinson’s disease
- Depression
- Gastroparesis
- Pain Management
- Tremors
- Urinary and Fecal Incontinence
Global Neurostimulation Devices Market: by End User analysis
- Hospitals/Clinics
- Cognitive Care Centers
- Research Institutes
- Others
Global Neurostimulation Devices Market: by Regional & Country Analysis
- North America
- US.
- Mexico
- Canada
- Europe
- UK
- France
- Germany
- Italy
- Asia Pacific
- China
- Japan
- India
- Southeast Asia
- Latin America
- Brazil
- The Middle East and Africa
- GCC
- Africa
- Rest of Middle East and Africa
About Us: Brandessence Market Research and Consulting Pvt. ltd.
Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.
Contact us at: +44-2038074155 or mail us at alan@brandessenceresearch.biz
Website: https://brandessenceresearch.biz
Related Report:
Medical Devices Industry Reports 2019
Ophthalmic Market Global Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025